Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults
- PMID: 35531712
- PMCID: PMC9348159
- DOI: 10.1111/joim.13504
Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults
Abstract
Background: Coronavirus disease 2019 (COVID-19) breakthrough infections are common.
Objective: Evaluate in-hospital mortality of patients with COVID-19 by vaccination status using retrospective cohort study.
Methods: We generated propensity scores for receipt of full vaccination in adults requiring supplemental oxygen hospitalized at Kaiser Permanente Northern California (1 April 2021 to 30 November 2021) with positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction tests. Optimal matching of fully vaccinated/unvaccinated patients was performed comparing in-hospital mortality.
Results: Of 7305 patients, 1463 (20.0%) were full, 138 (1.9%) were partial, and 5704 (78.1%) were unvaccinated. Fully vaccinated were older than partial or unvaccinated (71.0, 63.0, and 54.0 years, respectively, p < 0.001) with more comorbidities (Comorbidity Point Scores 33.0, 22.0, and 10.0, p < 0.001) and immunosuppressant (11.5%, 8.7%, and 3.0%, p < 0.001) or chemotherapy exposure (2.8%, 0.7%, and 0.4%, p < 0.001). Fewer fully vaccinated patients died compared to matched unvaccinated (9.0% vs. 16.3%, p < 0.0001).
Conclusion: Fully vaccinated patients are less likely to die compared to matched unvaccinated patients.
Keywords: COVID-19; breakthrough infection; hospitalization; mortality; vaccination.
© 2022 The Association for the Publication of the Journal of Internal Medicine.
Conflict of interest statement
Nicola P. Klein reports research support from Pfizer for COVID vaccine trials and from Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline, and Protein Science (now Sanofi Pasteur) for unrelated research. Gabriel J. Escobar, Vincent X. Liu, and Laura C. Myers report research support from Astra Zeneca unrelated to vaccine research. The other authors have no conflict of interest.
Similar articles
-
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.Clin Infect Dis. 2022 Aug 24;75(1):e849-e856. doi: 10.1093/cid/ciab1023. Clin Infect Dis. 2022. PMID: 34893812 Free PMC article.
-
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.JAMA Netw Open. 2022 May 2;5(5):e2213606. doi: 10.1001/jamanetworkopen.2022.13606. JAMA Netw Open. 2022. PMID: 35608859 Free PMC article.
-
First-Generation SARS-CoV-2 Vaccines: A Comparative Analysis between Vaccinated and Unvaccinated Hospitalized Patients Infected with SARS-CoV-2.Kathmandu Univ Med J (KUMJ). 2022 Jul-Sep;20(79):316-322. Kathmandu Univ Med J (KUMJ). 2022. PMID: 37042373
-
Disease Severity in Vaccinated Adults Hospitalized with Breakthrough COVID-19.Hosp Top. 2024 Oct-Dec;102(4):223-230. doi: 10.1080/00185868.2022.2118093. Epub 2022 Sep 10. Hosp Top. 2024. PMID: 36093610
-
Clinical manifestations of COVID-19 breakthrough infections: A systematic review and meta-analysis.J Med Virol. 2022 Sep;94(9):4234-4245. doi: 10.1002/jmv.27871. Epub 2022 Jun 1. J Med Virol. 2022. PMID: 35588301 Free PMC article.
Cited by
-
Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy.Pathogens. 2022 Jul 14;11(7):793. doi: 10.3390/pathogens11070793. Pathogens. 2022. PMID: 35890037 Free PMC article.
-
Evaluation of an outreach programme for patients with COVID-19 in an integrated healthcare delivery system: a retrospective cohort study.BMJ Open. 2024 Jan 8;14(1):e073622. doi: 10.1136/bmjopen-2023-073622. BMJ Open. 2024. PMID: 38191255 Free PMC article.
-
Vaccination Status and Outcome of Hospitalized Patients with Coronavirus Disease 2019 Before and After the Spread of Omicron Variant: An Observational Study from İzmir, Turkey.Thorac Res Pract. 2023 Nov;24(6):284-291. doi: 10.5152/ThoracResPract.2023.22234. Thorac Res Pract. 2023. PMID: 37721490 Free PMC article.
-
Multimorbidity and Frailty Are the Key Characteristics of Patients Hospitalized with COVID-19 Breakthrough Infection during Delta Variant Predominance in Italy: A Retrospective Study.J Clin Med. 2022 Sep 16;11(18):5442. doi: 10.3390/jcm11185442. J Clin Med. 2022. PMID: 36143095 Free PMC article.
References
-
- Haas EJ, Angulo FJ, Mclaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS‐CoV‐2 infections and COVID‐19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–29. 10.1016/S0140-6736(21)00947-8. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous